Bio

Benj Garrett, Managing Director, has been lead banker on well over a billion dollars of transactions while at Torreya, generating substantial amounts of the firm’s total revenue over multiple years. He joined the firm in 2008 and was made the youngest Managing Director. His experience crosses a wide spectrum in the life sciences, having led transactions as early as preclinical biotech, clinical stage, commercial stage and generics. Over a number of years, he has been successful in both origination and execution roles. His experience covers cross-boarder transactions from both Japanese and Indian pharmaceutical companies. Many of his clients have come back for repeat business, mandating Benj on successive transactions after positive experiences and outcomes. Recent notable transactions on which Benj has worked include Avenue Therapeutics sale to Cipla, Tris debt recapitalization and the acquisition of NextWave Pharmaceuticals from Pfizer, and Sawai acquisition of the generics business of Upsher-Smith. Benj graduated summa cum laude from NYU’s Stern School of Business, with a B.S. in finance and statistics.